Pathstone Family Office’s Gamida Cell Ltd. Ordinary Shares GMDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-21,786
Closed -$34.3K 1615
2022
Q3
$34.3K Buy
21,786
+10,893
+100% +$24.8K ﹤0.01% 1455
2022
Q2
$19.3K Sell
10,893
-453
-4% -$1.15K ﹤0.01% 1034
2022
Q1
$47K Sell
11,346
-420
-4% -$1.41K ﹤0.01% 944
2021
Q4
$30K Buy
11,766
+776
+7% +$2.56K ﹤0.01% 882
2021
Q3
$43K Buy
+10,990
New +$54.9K ﹤0.01% 852
2021
Q1
Sell
-4,500
Closed -$38K 1400
2020
Q4
$38K Buy
+4,500
New +$30.4K ﹤0.01% 568

Other funds holding GMDA

Pathstone Family Office's GMDA Position: Q4 2022 in Review

Pathstone Family Office sold out of Gamida Cell Ltd. Ordinary Shares (GMDA) in Q4 2022, closing a stake of 21,786 shares — an estimated $34.3K sold.

Pathstone Family Office first reported a position in GMDA in Q4 2020 and held it in 6 quarters. The position peaked at $47K in Q1 2022. 55 funds tracked by Wall St. Rank hold GMDA as of Q4 2022.

  • Pathstone Family Office reported no remaining Gamida Cell Ltd. Ordinary Shares position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 21,786 Gamida Cell Ltd. Ordinary Shares shares in Q4 2022, an estimated $34.3K.
  • Pathstone Family Office first reported a position in Gamida Cell Ltd. Ordinary Shares in Q4 2020 and held it in 6 quarters.
  • Pathstone Family Office's Gamida Cell Ltd. Ordinary Shares position peaked at $47K in Q1 2022.
  • 55 funds tracked by Wall St. Rank held Gamida Cell Ltd. Ordinary Shares as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.